Evaluation of Minimal Invasive Thyroidectomy
- Conditions
- GoiterThyroid
- Registration Number
- NCT05434715
- Lead Sponsor
- Kafrelsheikh University
- Brief Summary
The goals of minimally invasive approaches are better cosmetic results with small neck scar, decreasing postoperative pain, and shortening of hospital stay periods without postoperative complications.
The concept of surgical invasiveness cannot be limited to the length and site of the skin incision; it must be extended to all structures dissected during the procedure. Conventional thyroidectomy without raising subplatysmal flaps has proven to be effective in reducing postoperative pain and seroma
- Detailed Description
Minimal invasive flapless thyroidectomy (MIFT) is a new technique that can be used in replacement of the conventional method of thyroidectomy for the management of selected cases of benign thyroid disorders.
This work aims to evaluate the feasibility, safety, and efficacy of Minimal Invasive Flapless Thyroidectomy (MIFT) in the management of thyroid disease as regards postoperative pain, cosmesis, operative time, and other postoperative complications in comparison to Conventional thyroidectomy technique.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
- The limited size of the gland: volume less than 50 mm by ultrasound assessment. No evidence of retro-sternal extension. Benign nature of the disease proved by FNAC.
-
the patients who have one or more of the following criteria:
- The size of the gland is more than 50 mm by ultrasound assessment.
- Patients with retro-sternal goitre.
- Patients with proved malignancy or suspicious for malignancy by Ultrasonography(US) or by Fine-Needle Aspiration Cytology (FNAC).
- Previous surgery or radiotherapy to the neck.
- Thyroiditis.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Degree of satisification of cosmetic appearance of the thyroidectomy scar 12 months Degree of scar appearance satisification assessed by the patient and doctor using patient and observer scar assessment scale (POSAS) scale in both groups
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Kafrelsheikh University
🇪🇬Kafr Ash Shaykh, Kafr Al Sheikh, Egypt
Kafrelsheikh University🇪🇬Kafr Ash Shaykh, Kafr Al Sheikh, Egypt